Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Centrosome Aberrations in Bone Marrow Cells From Patients with Myelodysplastic Syndromes Correlate with Chromosomal Instability

Alice Fabarius, PhD, Michelle Giehl, PhD, Wiltrud Haass, Verena Nowak, Christiane Schumann, Daniel Nowak, MD, Maximilian Mossner, Torsten J Schulze, Stefan A. Klein, Wolfgang Seifarth, PhD, Wolf-Karsten Hofmann, Florian Nolte, MD

Blood (2012) 120 (21): 3839.

https://doi.org/10.1182/blood.V120.21.3839.3839

Published: 2012

Journal Articles

Molecular Response According to Type of Preexisting BCR-ABL Mutations after Second Line Dasatinib Therapy in Chronic Phase CML Patients.

Martin C. Mueller, MD, Philipp Erben, MD, Thomas Ernst, MD, Michelle Giehl, PhD, Thomas Schenk, MD, Jana Hoffmann, Stephanie Lauber, MD, Jens Kruth, MD, Benjamin Hanfstein, MD, Eric Bleickardt, MD, Claude Nicaise, MD, Rüdiger Hehlmann, MD, Andreas Hochhaus, MD

Blood (2007) 110 (11): 319.

https://doi.org/10.1182/blood.V110.11.319.319

Published: 2007

Journal Articles

Centrosome Aberrations, Disturbed Mitotic Spindle Formation and G1 Arrest in Normal and Leukemic Cells Treated with the SRC/ABL Inhibitor Dasatinib.

Alice Fabarius, PhD, Michelle Giehl, Alwin Kraemer, MD, Oliver Frank, PhD, Martin C. Mueller, MD, Peter Duesberg, PhD, Tanja Lahaye, MD, Claudia Schoch, MD, Rudiger Hehlmann, MD, Wolfgang Seifarth, PhD, Andreas Hochhaus, MD

Blood (2006) 108 (11): 2167.

https://doi.org/10.1182/blood.V108.11.2167.2167

Published: 2006

Journal Articles

Dynamics of Cytogenetic Aberrations in Philadelphia Chromosome Positive and Negative Hematopoiesis during Dasatinib Therapy of Chronic Myeloid Leukemia Patients after Imatinib Failure.

Alice Fabarius, PhD, Claudia Schoch, MD, Martin C. Mueller, MD, Philipp Erben, MD, Tanja Lahaye, MD, Michelle Giehl, Oliver Frank, PhD, Wolfgang Seifarth, PhD, Rudiger Hehlmann, MD, Andreas Hochhaus, MD

Blood (2006) 108 (11): 2114.

https://doi.org/10.1182/blood.V108.11.2114.2114

Published: 2006

Journal Articles

Centrosome Aberrations in Chronic Myeloid Leukemia (CML) Are Correlated with Disease Progression and Chromosome Instability.

Michelle Giehl, Alice Fabarius, Chun Zheng, Oliver Frank, Andreas Hochhaus, Mathias Hafner, Rudiger Hehlmann, Wolfgang Seifarth

Blood (2004) 104 (11): 2949.

https://doi.org/10.1182/blood.V104.11.2949.2949

Published: 2004

NARROW

Centrosome Aberrations in Bone Marrow Cells From Patients with Myelodysplastic Syndromes Correlate with Chromosomal Instability

Molecular Response According to Type of Preexisting BCR-ABL Mutations after Second Line Dasatinib Therapy in Chronic Phase CML Patients.

Centrosome Aberrations, Disturbed Mitotic Spindle Formation and G1 Arrest in Normal and Leukemic Cells Treated with the SRC/ABL Inhibitor Dasatinib.

Dynamics of Cytogenetic Aberrations in Philadelphia Chromosome Positive and Negative Hematopoiesis during Dasatinib Therapy of Chronic Myeloid Leukemia Patients after Imatinib Failure.

Centrosome Aberrations in Chronic Myeloid Leukemia (CML) Are Correlated with Disease Progression and Chromosome Instability.

Email alerts

ASH Publications

American Society of Hematology

Centrosome Aberrations in Bone Marrow Cells From Patients with Myelodysplastic Syndromes Correlate with Chromosomal Instability

Molecular Response According to Type of Preexisting BCR-ABL Mutations after Second Line Dasatinib Therapy in Chronic Phase CML Patients.

Centrosome Aberrations, Disturbed Mitotic Spindle Formation and G1 Arrest in Normal and Leukemic Cells Treated with the SRC/ABL Inhibitor Dasatinib.

Dynamics of Cytogenetic Aberrations in Philadelphia Chromosome Positive and Negative Hematopoiesis during Dasatinib Therapy of Chronic Myeloid Leukemia Patients after Imatinib Failure.

Centrosome Aberrations in Chronic Myeloid Leukemia (CML) Are Correlated with Disease Progression and Chromosome Instability.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only